Katherine E Yanosick

Safety and immunogenicity of a Zika purified inactivated virus vaccine given via standard, accelerated, or shortened schedules: a single-centre, double-blind, sequential-group, randomised, placebo-controlled, phase 1 trial.

Stephen J. Thomas, N. Michael, D. Barouch, 2020, The Lancet. Infectious diseases.